Buyse M, Piedbois P
International Institute for Drug Development, Brussels, Belgium.
Stat Med. 1996 Dec 30;15(24):2797-812. doi: 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V.
In this paper we review several approaches which have been used to investigate the relationship between survival time and response to treatment. We show that the approaches based on summary data are subjected to various types of biases (publication bias, confounding by prognostic features, ecologic bias) and are therefore of doubtful value. We also discuss several approaches based on individual patient data. Comparisons of survival by response are generally subject to length-biased sampling, and are therefore inadequate. The landmark method is adequate when responses occur soon after starting treatment, but not when responses may appear later in the course of the disease. For responses which can occur over extended periods of time, response must be considered as a time-dependent covariate. Using data from randomized trials in advanced colorectal cancer, we show that response is a potent and independent prognostic factor for survival in this disease. Analyses using the landmark method yield results essentially equivalent to those in which response is considered as a time-dependent covariate. The hazard rate of responders is about half that of non-responders, after taking the patient's performance status into account. The issue of response as a surrogate marker for survival is taken up further in a separate paper.
在本文中,我们回顾了几种用于研究生存时间与治疗反应之间关系的方法。我们表明,基于汇总数据的方法存在各种类型的偏差(发表偏倚、预后特征的混杂、生态偏倚),因此其价值存疑。我们还讨论了几种基于个体患者数据的方法。按反应比较生存情况通常会受到长度偏倚抽样的影响,因此并不充分。当反应在开始治疗后不久出现时,标志性方法是适用的,但当反应可能在疾病进程后期出现时则不然。对于可能在较长时间内出现的反应,必须将反应视为一个随时间变化的协变量。利用晚期结直肠癌随机试验的数据,我们表明反应是该疾病生存的一个有力且独立的预后因素。使用标志性方法进行的分析得出的结果与将反应视为随时间变化的协变量时的结果基本相当。在考虑患者的体能状态后,有反应者的风险率约为无反应者的一半。关于反应作为生存替代标志物的问题将在另一篇单独的论文中进一步探讨。